Primary Site >> Stomach Cancer
Gene >> SPINK1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: The measurement of serum immunoreactive pancreatic secretory trypsin inhibitor in gastrointestinal cancer and pancreatic disease. PMID: 2459273 |
Ref: [Determination of tumor-associated trypsin inhibitor (TATI) in subjects with gastrointestinal diseases. Preliminary data]. PMID: 2717042 |
Ref: Immunohistochemical study on pancreatic secretory trypsin inhibitor (PSTI) in gastric carcinomas. PMID: 2403744 |
Ref: Tumor-associated trypsin inhibitor (TATI) in benign and malignant gastric disease. PMID: 1780694 Ref: Tumor-associated trypsin inhibitor, TATI, in gastrointestinal cancer and related benign diseases. PMID: 1780697 |
Ref: Hyperamylasemia associated with lymphadenectomy in patients surgically treated for gastric cancer. PMID: 1374723 |
Ref: Specific expression of the pancreatic-secretory-trypsin-inhibitor (PSTI) gene in hepatocellular carcinoma. PMID: 8244568 |
Ref: Tumour markers and screening for gastrointestinal cancer: a follow up study in Finland. PMID: 8790487 |
Ref: Genetic polymorphisms of cytochrome p450 2E1, glutathione S-transferase M1 and T1, and susceptibility to gastric carcinoma in Taiwan. PMID: 12172927 |
Ref: Analysis of CYP2E1 polymorphism for the determination of genetic susceptibility to gastric cancer in Koreans. PMID: 14535982 |
Ref: High tissue expression of tumour-associated trypsin inhibitor (TATI) associates with a more favourable prognosis in gastric cancer. PMID: 15810949 |
Ref: Comparison of the prognostic value of a panel of tissue tumor markers and established clinicopathological factors in patients with gastric cancer. PMID: 18751407 |
Ref: Protective role of genetic polymorphism of heat shock protein 70-2 for gastric cancer risk. PMID: 18478330 |
Ref: Functional PstI/RsaI polymorphism in CYP2E1 is associated with the development, progression and poor outcome of gastric cancer. PMID: 22957075 Ref: Development of a survival prediction model for gastric cancer using serine proteases and their inhibitors. PMID: 22969854 Ref: CYP2E1 RsaI/PstI polymorphism and gastric cancer susceptibility: meta-analyses based on 24 case-control studies. PMID: 23139769 |
Ref: The relationship between serum tumor-associated trypsin inhibitor levels and clinicopathological parameters in patients with gastric cancer. PMID: 24254562 |
Ref: Association between CYP2E1 polymorphisms and risk of gastric cancer: An updated meta-analysis of 32 case-control studies. PMID: 27284439 |